Literature DB >> 3953862

Cortisol and Alzheimer's disease, I: Basal studies.

K L Davis, B M Davis, B S Greenwald, R C Mohs, A A Mathé, C A Johns, T B Horvath.   

Abstract

Patients with Alzheimer's disease and nondemented elderly control subjects participated in studies of cortisol secretion during sleep and at 9:00 a.m. and were given dexamethasone suppression tests (DSTs) and lumbar punctures. Nocturnal and 9:00 a.m. cortisol concentrations were significantly higher in the demented patients. CSF MHPG negatively correlated with mean nocturnal cortisol. The most severely demented patients had the highest 9:00 a.m. and mean nocturnal cortisol concentrations. DST results did not distinguish samples with substantially different nocturnal cortisol concentrations. These results suggest that measurements of basal plasma cortisol concentrations and dexamethasone suppression provide different information but support the notion of somewhat higher than normal cortisol concentrations in Alzheimer's disease patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3953862     DOI: 10.1176/ajp.143.3.300

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  50 in total

1.  Accelerated neurodegeneration through chaperone-mediated oligomerization of tau.

Authors:  Laura J Blair; Bryce A Nordhues; Shannon E Hill; K Matthew Scaglione; John C O'Leary; Sarah N Fontaine; Leonid Breydo; Bo Zhang; Pengfei Li; Li Wang; Carl Cotman; Henry L Paulson; Martin Muschol; Vladimir N Uversky; Torsten Klengel; Elisabeth B Binder; Rakez Kayed; Todd E Golde; Nicole Berchtold; Chad A Dickey
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

2.  Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease.

Authors:  Kim N Green; Lauren M Billings; Benno Roozendaal; James L McGaugh; Frank M LaFerla
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

3.  The Douglas Hospital Longitudinal Study of Normal and Pathological Aging: summary of findings.

Authors:  Sonia J Lupien; Georges Schwartz; Ying Kin Ng; Alexandra Fiocco; Nathalie Wan; Jens C Pruessner; Michael J Meaney; N P Vasavan Nair
Journal:  J Psychiatry Neurosci       Date:  2005-09       Impact factor: 6.186

4.  Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia.

Authors:  Christoph Laske; Elke Stransky; Andreas Fritsche; Gerhard W Eschweiler; Thomas Leyhe
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-09-19       Impact factor: 5.270

Review 5.  Glucocorticoids in Alzheimer's disease. The story so far.

Authors:  P S Aisen; G M Pasinetti
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

6.  Hypothalamic-pituitary-adrenal dysfunction in Apoe(-/-) mice: possible role in behavioral and metabolic alterations.

Authors:  J Raber; S F Akana; S Bhatnagar; M F Dallman; D Wong; L Mucke
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

Review 7.  Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability.

Authors:  Roberto Rodrigues; Robert B Petersen; George Perry
Journal:  Cell Mol Neurobiol       Date:  2014-06-14       Impact factor: 5.046

8.  Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid β fragment in rats.

Authors:  Charleine Zussy; Anthony Brureau; Brice Delair; Stephane Marchal; Emeline Keller; Guy Ixart; Gaelle Naert; Johann Meunier; Nathalie Chevallier; Tangui Maurice; Laurent Givalois
Journal:  Am J Pathol       Date:  2011-05-10       Impact factor: 4.307

9.  Age and sex differences of dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels in normal controls and Alzheimer's disease (AD).

Authors:  F Leblhuber; C Neubauer; M Peichl; F Reisecker; F X Steinparz; E Windhager; E Dienstl
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 10.  Adverse stress, hippocampal networks, and Alzheimer's disease.

Authors:  Sarah M Rothman; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2009-11-27       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.